Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1979 1
1980 4
1981 3
1982 8
1983 19
1984 10
1985 9
1986 18
1987 17
1988 27
1989 30
1990 47
1991 56
1992 81
1993 81
1994 72
1995 106
1996 139
1997 130
1998 121
1999 118
2000 123
2001 145
2002 116
2003 141
2004 122
2005 121
2006 121
2007 113
2008 109
2009 105
2010 106
2011 83
2012 94
2013 70
2014 82
2015 85
2016 74
2017 61
2018 64
2019 67
2020 75
2021 22
Text availability
Article attribute
Article type
Publication date

Search Results

3,018 results
Results by year
Filters applied: . Clear all
Page 1
Fluvoxamine.
[No authors listed] [No authors listed] 2021 Feb 15. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. Drugs and Lactation Database (LactMed). 2006–. PMID: 30000246 Free Books & Documents. Review.
If fluvoxamine is required by the mother, it is not a reason to discontinue breastfeeding. A safety scoring system finds fluvoxamine use to be possible during breastfeeding.[1] One infant was reported to have an elevated serum level of fluvoxamine, but most w …
If fluvoxamine is required by the mother, it is not a reason to discontinue breastfeeding. A safety scoring system finds fluvoxami …
Fluvoxamine-Associated Galactorrhea: A Case Report.
Chakladar A, Singh J, Tak NK, Patra BN, Sagar R. Chakladar A, et al. J Clin Psychopharmacol. 2020 Jan/Feb;40(1):101-102. doi: 10.1097/JCP.0000000000001160. J Clin Psychopharmacol. 2020. PMID: 31804454 No abstract available.
[Procognitive effects of fluvoxamine: preliminary data].
Bobrov AE, Krasnoslobodtseva LA, Mutnykh EM. Bobrov AE, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6):43-49. doi: 10.17116/jnevro20181186143. Zh Nevrol Psikhiatr Im S S Korsakova. 2018. PMID: 30040800 Russian.
AIM: To identify and investigate procognitive effects of fluvoxamine. MATERIAL AND METHODS: A prospective non-comparative trial of fluvoxamine was carried out in 50 patients in the remission phase of recurrent depressive disorder. ...CONCLUSION: Fluvoxamine h …
AIM: To identify and investigate procognitive effects of fluvoxamine. MATERIAL AND METHODS: A prospective non-comparative trial of …
Pharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders.
Altamura AC, Caldiroli A, Buoli M. Altamura AC, et al. Expert Opin Drug Metab Toxicol. 2015 Apr;11(4):649-60. doi: 10.1517/17425255.2015.1021331. Epub 2015 Mar 1. Expert Opin Drug Metab Toxicol. 2015. PMID: 25728382 Review.
INTRODUCTION: Fluvoxamine is one of the most widely prescribed antidepressants and presents data from 30 years of clinical experience. AREAS COVERED: The present review article describes the pharmacokinetic properties of fluvoxamine and their implications for the tr …
INTRODUCTION: Fluvoxamine is one of the most widely prescribed antidepressants and presents data from 30 years of clinical experience …
Effect of Fluvoxamine on Amyloid-beta Peptide Generation and Memory.
Kim WS, Fu Y, Dobson-Stone C, Hsiao JT, Shang K, Hallupp M, Schofield PR, Garner B, Karl T, Kwok JBJ. Kim WS, et al. J Alzheimers Dis. 2018;62(4):1777-1787. doi: 10.3233/JAD-171001. J Alzheimers Dis. 2018. PMID: 29614681
We therefore hypothesized that fluvoxamine treatment would reduce Abeta production and improve cognition. We firstly investigated the impact of SIGMAR1 on AbetaPP processing, and found that overexpression and knockdown of SIGMAR1 significantly affected gamma-secretase acti …
We therefore hypothesized that fluvoxamine treatment would reduce Abeta production and improve cognition. We firstly investigated the …
A fluvoxamine-related fatality: Case report with postmortem concentrations.
Otter J, McIntyre IM, Morhaime J, Cantrell L. Otter J, et al. Forensic Sci Int. 2019 Jul;300:e31-e33. doi: 10.1016/j.forsciint.2019.02.047. Epub 2019 Mar 1. Forensic Sci Int. 2019. PMID: 30871740
Fluvoxamine is a selective serotonin reuptake inhibitor that has been considered relatively safe in overdose. ...His cause of death was determined to be acute fluvoxamine toxicity....
Fluvoxamine is a selective serotonin reuptake inhibitor that has been considered relatively safe in overdose. ...His cause of death w …
Fluvoxamine-induced intracranial hypertension in a 10-year-old boy.
Samant H, Samant P. Samant H, et al. Indian J Ophthalmol. 2018 May;66(5):712-714. doi: 10.4103/ijo.IJO_833_17. Indian J Ophthalmol. 2018. PMID: 29676327 Free PMC article.
We report a rare case of intracranial hypertension with papilledema in a 10-year-old boy following use of fluvoxamine, a selective serotonin reuptake inhibitor. On discontinuing the drug, the papilledema resolved over 4 months without any residual visual anomalies. To the …
We report a rare case of intracranial hypertension with papilledema in a 10-year-old boy following use of fluvoxamine, a selective se …
A review of fluvoxamine and its uses in depression.
Burton SW. Burton SW. Int Clin Psychopharmacol. 1991 Dec;6 Suppl 3:1-17; discussion 17-21. doi: 10.1097/00004850-199112003-00001. Int Clin Psychopharmacol. 1991. PMID: 1806631 Review.
The effectiveness of fluvoxamine in depression is therefore analysed in this review, on the basis of ten years experience. ...Effectiveness in the elderly depressed and support for the use of fluvoxamine in tricyclic-resistant depression is discussed. Clinical trial …
The effectiveness of fluvoxamine in depression is therefore analysed in this review, on the basis of ten years experience. ...Effecti …
Overview of the pharmacokinetics of fluvoxamine.
van Harten J. van Harten J. Clin Pharmacokinet. 1995;29 Suppl 1:1-9. doi: 10.2165/00003088-199500291-00003. Clin Pharmacokinet. 1995. PMID: 8846617 Review.
Fluvoxamine undergoes extensive oxidative metabolism, most probably in the liver. ...Plasma protein binding of fluvoxamine (77%) is low compared with that of other SSRIs. Fluvoxamine pharmacokinetics are substantially unaltered by increased age or renal impai …
Fluvoxamine undergoes extensive oxidative metabolism, most probably in the liver. ...Plasma protein binding of fluvoxamine (77 …
The antidepressant-like effects of fluvoxamine in mice involve the mTOR signaling in the hippocampus and prefrontal cortex.
Xu D, Wang C, Zhu X, Zhao W, Jiang B, Cui S, Sun Y, Cui Z. Xu D, et al. Psychiatry Res. 2020 Mar;285:112708. doi: 10.1016/j.psychres.2019.112708. Epub 2019 Nov 25. Psychiatry Res. 2020. PMID: 31810748
Although thought as a selective serotonin reuptake inhibitor (SSRI), the antidepressant mechanisms of fluvoxamine remain elusive. Therefore, this study aims to evaluate whether mTOR underlies the antidepressant-like effects of fluvoxamine. ...Taken together, the mTO …
Although thought as a selective serotonin reuptake inhibitor (SSRI), the antidepressant mechanisms of fluvoxamine remain elusive. The …
3,018 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page